Long-Term Survival in Unresectable Malignant Peritoneal Mesothelioma With PIPAC: A Case Report
SOHO-02 Trial Investigates BAY 2927088 as Frontline Treatment for HER2-Positive NSCLC
OptiTROP-Lung03 Evaluates Sacituzumab Tirumotecan in EGFR-Mutated NSCLC
FDA Grants Accelerated Approval of Sunvozertinib for Metastatic EGFR-Positive NSCLC
AEGEAN: Analysis Explores Impact of Post-Surgical MRD Status in NSCLC
Study Investigates Targeted Interventions to Improve Lung Cancer Screening Uptake in High-Risk Patients